Related Experiment Video
Updated: May 21, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age
Matti Hiltunen1, Tuomas Kerola, Raimo Kettunen
1Department of Clinical Neurophysiology, Helsinki University Central Hospital, FI-00290 Helsinki, Finland.
Introduction:
It is known that blood levels of natriuretic peptides associate with cognitive disorder among the middle-aged. We aimed to test whether this association is valid in an older population aged 75 years or older.
Methods:
A total of 601 older subjects aged 75 or older participated in the study. A subgroup of 137 with a diagnosed cognitive disorder were tested for natriuretic peptides (ANP, NT-proANP, and BNP), and compared with age-matched controls (n = 464). The control group was followed-up for 5 years, and the association of the baseline BNP with the occurrence of cognitive impairment was studied.
Results:
In the youngest age tertile (75-78 y), BNP was significantly associated with a diagnosed cognitive disorder when other factors with a known effect on natriuretic peptides were taken into account. In the oldest tertile (83-96 y), higher BNP values suggested the absence of cognitive dysfunction. ANP and NT-proANP did not associate with the presence of cognitive impairment. Among the control group, BNP predicted a cognitive disorder at follow-up, but only in the youngest tertile.
Conclusions:
The previously found link between a high BNP concentration and cognitive disorder in older people is only valid among those aged less than 79 years.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cognitive Development During Adulthood
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Alzheimer Disease l: Introduction
